185 related articles for article (PubMed ID: 2568945)
1. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism.
Schneider JS; Yuwiler A
Exp Neurol; 1989 Aug; 105(2):177-83. PubMed ID: 2568945
[TBL] [Abstract][Full Text] [Related]
2. GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.
Hadjiconstantinou M; Mariani AP; Neff NH
Brain Res; 1989 Apr; 484(1-2):297-303. PubMed ID: 2565752
[TBL] [Abstract][Full Text] [Related]
3. Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment.
Schneider JS; Pope A; Simpson K; Taggart J; Smith MG; DiStefano L
Science; 1992 May; 256(5058):843-6. PubMed ID: 1350379
[TBL] [Abstract][Full Text] [Related]
4. Effects of GM1 ganglioside treatment on dopamine innervation of the striatum of MPTP-treated mice.
Rothblat DS; Schneider JS
Ann N Y Acad Sci; 1998 Jun; 845():274-7. PubMed ID: 9668361
[TBL] [Abstract][Full Text] [Related]
5. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Rothblat DS; Schneider JS
Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
[TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
Schneider JS; Kean A; DiStefano L
J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
[TBL] [Abstract][Full Text] [Related]
7. Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.
Date I; Felten SY; Felten DL
Neurosci Lett; 1989 Dec; 106(3):282-6. PubMed ID: 2601883
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
Schneider JS; DiStefano L
Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837
[TBL] [Abstract][Full Text] [Related]
9. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
[TBL] [Abstract][Full Text] [Related]
10. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
[TBL] [Abstract][Full Text] [Related]
11. Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
Hadjiconstantinou M; Neff NH
J Neurochem; 1988 Oct; 51(4):1190-6. PubMed ID: 3262149
[TBL] [Abstract][Full Text] [Related]
12. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
Schneider JS
J Neurosci Res; 1992 Jan; 31(1):112-9. PubMed ID: 1613817
[TBL] [Abstract][Full Text] [Related]
13. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice.
Fazzini E; Durso R; Davoudi H; Szabo GK; Albert ML
J Neurol Sci; 1990 Oct; 99(1):59-68. PubMed ID: 2250172
[TBL] [Abstract][Full Text] [Related]
14. Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Schneider JS
Neuropharmacology; 1992 Feb; 31(2):185-92. PubMed ID: 1553028
[TBL] [Abstract][Full Text] [Related]
15. Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.
Hadjiconstantinou M; Rossetti ZL; Paxton RC; Neff NH
Neuropharmacology; 1986 Sep; 25(9):1075-7. PubMed ID: 3490632
[TBL] [Abstract][Full Text] [Related]
16. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
Schneider JS; DiStefano L
Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
[TBL] [Abstract][Full Text] [Related]
17. Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice.
Weihmuller FB; Hadjiconstantinou M; Bruno JP; Neff NH
Neurosci Lett; 1988 Oct; 92(2):207-12. PubMed ID: 2903475
[TBL] [Abstract][Full Text] [Related]
18. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
Pope-Coleman A; Tinker JP; Schneider JS
Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
[TBL] [Abstract][Full Text] [Related]
19. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.
Hadjiconstantinou M; Neff NH
Eur J Pharmacol; 1990 May; 181(1-2):137-9. PubMed ID: 1974854
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
Schneider JS; Denaro FJ
J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]